PuSH - Publication Server of Helmholtz Zentrum München: Azacitidine in combination with the selective FLT3 kinase inhibitor crenolanib effectively disrupts stromal protection of CD34+Leukemia-Initiating Cells (LIC) in FLT3-ITD+ Acute Myeloid Leukemia (AML).

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... Journal

... Publication Type

... Research Data

... Publication Year

Publication overview

Support & Contact

Contact persons

Help

Data protection

Garz, A.-K.* ; Habringer, S.* ; Wolf, S.* ; Vick, B. ; Weickert, M.-T.* ; Jeremias, I. ; Spiekermann, K.* ; Peschel, C.* ; Oostendorp, R.A.J.* ; Keller, U.* ; Goetze, K.S.*

Azacitidine in combination with the selective FLT3 kinase inhibitor crenolanib effectively disrupts stromal protection of CD34+Leukemia-Initiating Cells (LIC) in FLT3-ITD+ Acute Myeloid Leukemia (AML).

Blood 126 (2015)

Open Access Green as soon as Postprint is submitted to ZB.

Abstract
Metrics
Extra information

Additional Metrics?

[➜Log in]

Edit extra informations Login

Publication type Article: Journal article

Document type Meeting abstract

Corresponding Author

ISSN (print) / ISBN 0006-4971

e-ISSN 1528-0020

Journal Blood

Quellenangaben Volume: 126, Issue: 23

Publisher American Society of Hematology

Publishing Place Washington

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) Research Unit Gene Vector (AGV)
CCG Pathogenesis of Acute Myeloid Leukemia (KKG-KPL)